Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Myeloid 3Other hematologic neoplasm 1Classical hematology 1

Conditions

Breast Neoplasms 13cyclopia sequence 7Neoplasms 6Multiple Myeloma 6Fatigue 6Neoplasms, Plasma Cell 5Neoplasm Metastasis 4Lung Neoplasms 4Dyspnea 4Carcinoma, Non-Small-Cell Lung 4Anxiety Disorders 4Uterine Cervical Neoplasms 3Tobacco Use Cessation 3Prostatic Neoplasms 3Primary Myelofibrosis 3Leukemia 3Head and Neck Neoplasms 3Depression 3Carcinoma, Renal Cell 3Vomiting 2Smoking Cessation 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycythemia Vera 2Parasomnias 2Pancreatic Neoplasms 2Pain 2Osteosarcoma 2Kidney Neoplasms 2Hodgkin Disease 2Hematologic Neoplasms 2

Interventions

fludarabine phosphate 31Cyclophosphamide 27Mycophenolic Acid 22Whole-Body Irradiation 21Tacrolimus 21ruxolitinib 19Peripheral Blood Stem Cell Transplantation 19Busulfan 19Antilymphocyte Serum 16fludarabine 14Melphalan 12Methotrexate 11Cyclosporine 10thymoglobulin 9Cord Blood Stem Cell Transplantation 7Sirolimus 6Radiotherapy 6Etoposide 6Azacitidine 6Stem Cell Transplantation 5Granulocyte Colony-Stimulating Factor 5Cyclosporins 4pomalidomide 3parsaclisib 3Surveys and Questionnaires 3Rituximab 3Prednisone 3Filgrastim 3Cytarabine 311-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Has results × Primary Myelofibrosis × Surveys and Questionnaires × Clear all
NCT02730884 2020-08-07

Single-Arm Study of the Efficacy and Safety of Oral Rigosertib in Patients With Myelofibrosis (MF) and Anemia

M.D. Anderson Cancer Center

Phase 2 Terminated
3 enrolled 6 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Leukemia, Splenomegaly, Primary Myelofibrosis

NCT02267278 2019-06-12

Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)

M.D. Anderson Cancer Center

Phase 2 Completed
25 enrolled 8 charts
Myeloid

Polycythemia Vera, Primary Myelofibrosis

NCT02410551 2018-10-30

Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)

M.D. Anderson Cancer Center

Phase 2 Terminated
4 enrolled 5 charts
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡